Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality

Oncogene volume 20, pages 874–878 (2001)Cite this article

Abstract

Rearrangements of the human ALL-1 gene are frequently encountered in acute lymphocytic leukemias (ALL) and acute myeloid leukemias (AML). These rearrangements are mostly due to chromosome translocations and result in production of chimeric proteins composed of the N-terminal fragment of ALL-1 and the C-terminal segments of the partner proteins. The most common chromosome translocation involving ALL-1 is the t(4 : 11) associated with ALL. ALL-1 is the human homologue of Drosophila trithorax and directly activates transcription of multiple Hox genes. A preliminary DNA microarray screen indicated that the Meis1, HoxA9 and AC133 genes were overexpressed in ALLs with t(4 : 11), compared to ALLs with very similar phenotype but without the chromosomal abnormality. These genes, as well as additional five Hox genes, were subjected to comprehensive semi-quantitative or quantitative RT–PCR analysis in 57 primary ALL and AML tumors. Meis1 and HoxA9 were found expressed in 13/14 of ALLs with the t(4 : 11) and in 8/8 of AMLs with ALL-1 rearrangements. The two genes were not consistently transcribed in other types of ALL. AC133 was transcribed in 13/14 of ALLs with t(4 : 11), but in only 4/8 of AMLs with ALL-1 rearrangements. HoxA10 was expressed in most leukemias with ALL-1 alterations, but was also transcribed in PrePreB CD10− ALLs lacking the t(4 : 11). Expression of HoxA5, HoxA7, HoxC8 and HoxC10 did not correlate with ALL-1 rearrangements. Coexpression of Meis1 and HoxA9, overexpression of HoxA10, and overexpression or fusion of HoxA9 were previously implicated in certain acute myeloid leukemias in mice and humans. The present work suggests that upregulation of Meis1, HoxA9, and possibly HoxA10 might also play a role in pathogenesis of acute lymphocytic and acute myeloid leukemias associated with ALL-1 fusions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Afonja O, Smith J, Ohyashiki K, Toyama K, Inghirami G and Takeshita K. . 1997 Blood 90: 67a.

  • Borrow J, Shearman AM, Stanton VPJ, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J and Housman DE. . 1996 Nat. Genet. 12: 159–167.

  • Brown PO and Botstein D. . 1999 Nat. Genet. 21: 33–37.

  • Bühring H-J, Seiffert M, Marxer A, Weis B, Faul C, Kanz L and Brugger W. . 1999 Blood 94: 832–833.

  • Chen C-S, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD and Kersey JH. . 1993 Blood 81: 2386–2393.

  • Cimino G, Rapanotti MC, Rivolta A, LoCoco F, D'Archangelo E, Rondelli R, Basso G, Borisone E, Rosanda C, Santostasi T, Canaani E, Masera G, Mandelli F and Biondi A. . 1995 Leukemia 9: 391–395.

  • Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie ANJ, King G and Rabbits TH. . 1996 Cell 85: 853–861.

  • DiMartino JF and Cleary ML. . 1999 Br. J. Hemat. 106: 614–626.

  • Dobson CL, Warren AJ, Pannell R, Forster A and Rabbits TH. . 2000 EMBO J. 19: 843–851.

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caliguri MA, Bloomfield CD and Lander ES. . 1999 Science 286: 531–537.

  • Griesinger F, Elfers H, Ludwig W-D, Falk M, Rieder H, Harbott J, Lampert F, Heinze B, Hoelzer D, Thiel E, Riehm H, Wörmann B, Fonatsch C and Hiddemann W. . 1994 Leukemia 8: 542–548.

  • Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM and Canaani E. . 1992 Cell 71: 701–708.

  • Hanson RD, Hess JL, Yu BD, Ernst P, van Lohuizen M, Berns A, van der Lugt NMT, Shashikant CS, Ruddle FH, Seto M and Korsmeyer SJ. . 1999 Proc. Natl. Acad. Sci. USA 96: 14372–14377.

  • Higuchi R, Fockler C, Dollinger G and Watson R. . 1993 Biotechnology 11: 1026–1030.

  • Hoffman R, Benz EJ, Shatill SJ, Furie B, Cohen HJ, Silberstein LE and McGlave P. . 2000 Hematology: Basic principles and practice. Churchill Livingstone.

    Google Scholar 

  • Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welbron JL, Wilman CL and Cleary ML. . 1993 Blood 81: 3197–3202.

  • Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S and Seckler-Walker LM. . 1998 Leukemia 12: 779–787.

  • Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM and Sauvageau G. . 1998 EMBO J. 17: 3714–3725.

  • Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, Kömüves L, Buchberg AM and Largman C. . 1999 Leukemia 13: 1993–1999.

  • Lee GC, Foerster J, Lukens J, Paraskevas F, Greer JP and Rodgers GM. . 1999 Wintrobes Clinical Hematology. Williams & Wilkins.

    Google Scholar 

  • Lin RJ and Evans RM. . 2000 Mol. Cell 5: 821–830.

  • Moscow JJ, Bullrich F, Huebner K, Daar IO and Buchberg AM. . 1995 Mol. Cell Biol. 15: 5434–5443.

  • Minucci S, Maccarana M, Cioce M, DeLuca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Bianchini A, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C and Pelicci PG. . 2000 Mol. Cell 5: 811–820.

  • Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen I-M, Feinberg AP, Jenkins NA, Copeland NG and Shaughnessy Jr JD. . 1996a Nat. Genet. 12: 154–158.

  • Nakamura T, Largaespada DA, Shaughnessy JD, Jenkins NA and Copeland NG. . 1996b Nat. Genet. 12: 149–153.

  • Pui C-H, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP, Beham FG and Borowitz MJ. . 1991a Blood 77: 440–447.

  • Pui C-H, Ribiero RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behon FG, Mahmoud MH, Sandlund JT and Crist WM. . 1991b N. Engl. J. Med. 325: 1682–1684.

  • Rozovskaia T, Tillib S, Smith S, Sedkov Y, Rozenblatt-Rosen O, Petruk S, Yano T, Nakamura T, Ben-Simchon L, Gildea J, Croce CM, Shearn A, Canaani E and Mazo A. . 1999 Mol. Cell Biol. 19: 6441–6447.

  • Schena M, Shalon D, Heller R, Chai A, Brown PO and Davis RW. . 1996 Proc. Natl. Acad. Sci. USA 93: 10614–10619.

  • Schichman SA, Canaani E and Croce CM. . 1995 J. Am. Med. Assoc. 273: 571–576.

  • Schnabel CA, Jakobs Y and Cleary ML. . 2000 Oncogene 19: 608–616.

  • Shen W-F, Rozsenfeld S, Kwong A, Kömüves LG, Lawrence HJ and Largman C. . 1999 Mol. Cell Biol. 19: 3051–3061.

  • Slany RK, Lavau C and Cleary ML. . 1998 Mol. Cell Biol. 18: 122–129.

  • Thorsteindottier U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C and Humphries RK. . 1997 Mol. Cell Biol. 17: 495–505.

  • Tillib S, Petruk S, Sedkov Y, Kuzin A, Fujioka M, Goto T and Mazo A. . 1999 Mol. Cell Biol. 19: 5189–5202.

  • Tkachuk DC, Kohlers S and Cleary ML. . 1992 Cell 71: 691–700.

  • Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA and Balis UJ. . 1997 Biotechniques 22: 176–181.

  • Yin AH, Miraglia S, Zanjan ED, Ameida-Porada G, Ogawa M, Leary AG, Olweus J, Kearny J and Buck DW. . 1997 Blood 90: 5002–5012.

  • Yu BD, Hanson R, Hess J, Horning SE and Korsmeyer SJ. . 1995 Nature 378: 505–508.

Download references

Acknowledgements

This work was supported by grants from the Israel Cancer Research Fund, the Israeli Academy of Science, the German Institute of Cancer Research, the Louis and Fannie Tolz Fund for Cooperation between the Weizmann Institute of Science and Thomas Jefferson University, by NCI grant CA 50507 and by grants from Associazione Italiana per la Ricerca il Cancro (AIRC - Milan), Associazione Italiana per la Lotta le Leucemie - sezione di ROMA (ROMAIL).

Author information

Author notes

  1. E Canaani

    Present address: Thomas Jefferson University, Kimmel Cancer Center, BLSB, Room 608, 233 S. 10th Street, Philadelphia, PA 19107-5541, USA

Authors and Affiliations

  1. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel

    T Rozovskaia, J Blechman & E Canaani

  2. Ouark Biotech Inc., 1059 Serpentine Lane, Pleasanton, CA 942566, USA

    E Feinstein & O Mor

  3. Department of Human Biopathology of the University ‘La Sapienza’, Via Benevento 6, Rome, 00161, Italy

    R Foa & G Cimino

  4. Kimmel Cancer Institute, Jefferson Medical College, Philadelphia, PA 19107, Pennsylvania, USA

    T Nakamura & C M Croce

Authors
  1. T Rozovskaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Feinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O Mor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Foa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Blechman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C M Croce
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Cimino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E Canaani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rozovskaia, T., Feinstein, E., Mor, O. et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Oncogene 20, 874–878 (2001). https://doi.org/10.1038/sj.onc.1204174

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204174

Keywords

This article is cited by

Search

Advanced search

Quick links